However, IFN-γ also exhibits paradoxical tumor-promoting effects by upregulating the expression of immune checkpoint ligands on tumor cells and T lymphocytes via the JAK-STAT-IRF-1 pathway, thereby complicating immune responses within the TME [33,34]. The gene discussed is IRF1; the disease is neoplasm.